On October 13, SBP GROUP fell 3.15% in regular trading, trading at HK$5.235/share, with Turnover of HK$48.86 million.

Within the Pharmaceuticals sector where SBP GROUP belongs, sector sentiment was broadly weak. Among individual stocks, CSPC PHARMA fell 2.16%, HENGRUI PHARMA fell 1.65%, HANSOH PHARMA fell 1.33%, HUTCHMED fell 2.53%, and CHINARES PHARMA was flat at 0%.

SBP GROUP is an investment holding company primarily engaged in pharmaceutical operations through three segments: modernized traditional Chinese medicine preparations and western medicines, investment, and others, covering drug R&D, production, and sales.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)